deaths from tirzepatide reduces CV death, worsening HF in o Zepbound, Eli Lilly (LLY) Weight-Loss

confirmed MT-2's erectogenic properties in a double-blind trial 8 of 10 men with psychogenic ED developed clinically apparent erections (Wessells et al., 1998)

Unexpected complications such as gallbladder inflammation or pancreatitis emerging with long-term use

Those are different problems, so the better option is often different too

Per the terms of use, you're responsible for paying for your initial evaluation and any ordered labs "even if you do not meet the clinical criteria for treatment," and that cost is explicitly stated as not included in the price of the medication itself

10.1016/j.biopha.2019.109455 42 HuJ.ZhangY

The most basic question whether the drug leads to positive health outcomes in addition, rather than simply weight loss is still somewhat hazy, although early signs are promising, with patients showing improved blood pressure, blood glucose, cholesterol, and various other key health markers